Colony Family Offices’s iShares Biotechnology ETF IBB Stock Holding History

Colony Family Offices’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-23	Closed	-$3.04K	–	74
2024 Q4	$3.04K	Buy	+23	New	+$3.23K	﹤0.01%	78
2024 Q2	–	Sell	-3,485	Closed	-$478K	–	64
2024 Q1	$478K	Hold	3,485	–	–	0.15%	48
2023 Q4	$473K	Buy	+3,485	New	+$425K	0.16%	48
2023 Q2	–	Sell	-500	Closed	-$64.6K	–	68
2023 Q1	$64.6K	Buy	+500	New	+$65.5K	0.02%	88

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

MMEA

Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

Colony Family Offices's IBB Position: Q1 2025 in Review

Colony Family Offices sold out of iShares Biotechnology ETF (IBB) in Q1 2025, closing a stake of 23 shares — an estimated $3.04K sold.

Colony Family Offices first reported a position in IBB in Q1 2023 and held it in 4 quarters. The position peaked at $478K in Q1 2024. 831 funds tracked by Wall St. Rank hold IBB as of Q1 2025.

Colony Family Offices reported no remaining iShares Biotechnology ETF position as of Q1 2025 after selling out during the quarter.
Colony Family Offices sold 23 iShares Biotechnology ETF shares in Q1 2025, an estimated $3.04K.
Colony Family Offices first reported a position in iShares Biotechnology ETF in Q1 2023 and held it in 4 quarters.
Colony Family Offices's iShares Biotechnology ETF position peaked at $478K in Q1 2024.
831 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2025.

Based on Colony Family Offices's 13F filing for Q1 2025, filed 21 Apr 2025.